Paxman

Focus: Paxman is a UK-based biotechnology company specializing in scalp cooling systems designed to prevent chemotherapy-induced hair loss and related conditions in cancer patients. The company operates as a focused medical device and therapeutic innovator with a narrow but clinically important product portfolio.

Unknown

Profile data last refreshed 1h ago · AI intelligence enriched 2w ago

Open Jobs

About Paxman

AI assessmentNot Hiring

No open roles listed right now. Follow Paxman to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

8 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Paxman Scalp Cooling System

Alopecia, Breast Cancer, Metastatic Breast Cancer

Growth

Lead product addressing chemotherapy-induced alopecia with multiple indications and Phase 2 development ongoing for metastatic breast cancer.

Paxman Cryocompression System / Limb Cryocompression System

Chemotherapy-induced Peripheral Neuropathy

Help build intelligence for Paxman

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Specialized focus on unmet oncology supportive care needs with 8 pipeline programs targeting chemotherapy side effects and cancer-related conditions
Active clinical development in scalp cooling for breast cancer and expansion into chemotherapy-induced peripheral neuropathy via cryocompression systems
UK-based headquarters in Huddersfield provides European biotech exposure with potential access to NHS commercialization pathways

Watch Out For

Only 1 active job opening signals minimal hiring velocity and limited career mobility within the organization
No published financials, funding data, or revenue information available—raises transparency and stability concerns for job security assessment
Sparse clinical trial activity (6 total trials, no Phase 3 programs) and no recent news or publications suggest limited clinical momentum or visibility in the field

Generated by Claude from Paxman's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Expansion into peripheral neuropathy management represents pipeline diversification beyond scalp cooling into complementary oncology supportive care.

Pipeline & Clinical Trials

Paxman Scalp Cooling System

Alopecia

N/A

Clinical Trials (1)

NCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region

N/A

Paxman Scalp Cooling Device

Breast Cancer

N/A

Clinical Trials (1)

NCT04626895Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers

N/A

Scalp cooling with hairstyle

Alopecia

N/A

Clinical Trials (1)

NCT05213936Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color